drugset / Trial / NCT05457894
Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women
RandomizedParallel-groupDouble-blindPrevention
Summary
Comparative study of tolerability, reactogenicity, safety and immunogenicity Flu-M \[Inactivated Split Influenza Vaccine\] vs. the Ultrix® vaccine for the prevention of influenza in pregnant women in the 2nd-3rd trimesters of pregnancy
Timeline
- Start
- 2020-01-23
- Primary completion
- 2021-03-11
- Completion
- 2021-07-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flu-M | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Ultrix | Vaccine | 0.5 ml | Intramuscular |